OpenClinica
Founded 2004 · 76 employees on LinkedIn · 1 known investors
Find your way into OpenClinica
Sign up to see every warm intro you have to OpenClinica
- Paths you didn't know you had: your email and LinkedIn already hold routes to the OpenClinica team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
OpenClinica eConsent is a digital consent platform for clinical trials that enables participants to review and electronically sign informed consent forms using media-rich content on any device. It serves academic researchers, sponsors, contract research organizations (CROs), and clinical trial sites who need to streamline enrollment while maintaining regulatory compliance across decentralized, hybrid, and in-person studies.
Founders & leadership
OpenClinica was founded in 2004 by Joe Keremian.
Investors · 1
Frequently asked questions
- What does OpenClinica do?
- OpenClinica eConsent is a digital consent platform for clinical trials that enables participants to review and electronically sign informed consent forms using media-rich content on any device. It serves academic researchers, sponsors, contract research organizations (CROs), and clinical trial sites who need to streamline enrollment while maintaining regulatory compliance across decentralized, hybrid, and in-person studies.
- Who founded OpenClinica?
- OpenClinica was founded by Joe Keremian in 2004.
- Who are OpenClinica's investors?
- OpenClinica's investors include Thompson Street Capital Partners.


